An Ambispective Cohort Study of Orelabrutinib in Combination With Standard Treatment Regimen for Untreated DLBCL
Clinical trial NCT06015464 · UNKNOWN
Trial details
- NCT number
- NCT06015464
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-01
- Primary completion
- 2024-12-30
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.